Reviticell is commercializing a unique medical device that will make regenerative medicine treatments available on a massive scale. Patent-pending Reviticell Kits will unlock the potential to heal that lies dormant within our bodies.
Reviticell is a dynamic company that is commercializing a unique point-of-care system that will make regenerative medicine treatments available on a massive scale. The promise of regenerative medicine is leveraging the power within your own body to heal or change the course of disease. Patent-pending Reviticell Kits will unlock this potential that would otherwise lie dormant.
Doctors can use Reviticell Kits to prepare Orthopedic & Sports, Wound Care and Medical Aesthetics treatments, as well as to restore and reconstruct tissue systems which may have become depleted due to aging, damage from trauma or birth defects. Reviticell Kits are One-System-for-Many-Therapies because of the underlying modular structure which can be configured for numerous treatment preparation protocols.
Reviticell Kits are standardized medical devices that doctors can use to safely and efficiently prepare regenerative medicine treatments with predictable and consistent outcomes. The inherent efficiency of these devices can reduce medical costs and the step-by-step protocol of each Reviticell Kit can reduce the risk of medical errors.
The emerging field of regenerative medicine is projected to grow to an $83 billion industry by 2020 and Reviticell Kits are positioned to become the industry standard. Reviticell is poised to commercialize and immediately scale-up by leveraging the resources of its strategic business partners. These world-class companies have an existing market presence and significant influence in the medical industry.
Reviticell’s management team has extensive experience in product and business development, marketing and sales, and managing successful high-growth businesses in multiple markets in the US and abroad. This team includes an MD who leads Regenerative Medicine at University of Florida, a PhD who is an industry veteran, and others who have worked with or for medical-device-industry giants and have start-up experience.
Patent-pending Reviticell Kits will unlock the potential to heal that lies dormant within our bodies. Doctors can use Reviticell Kits to prepare blood for treatments in Orthopedic & Sports, Wound Care and Medical Aesthetics markets. Reviticell Kits can also be used to prepare tissue for the restoration and reconstruction of tissue systems which may have become depleted due to age, damage from trauma or birth defects.
Reviticell Kits are standardized point-of-care medical devices that doctors can use to safely and efficiently prepare regenerative medicine treatments with predictable and consistent outcomes. The inherent efficiency of these devices can reduce medical costs and the step-by-step protocol of each Reviticell Kit can reduce the risk of medical errors. No other product can be used to prepare any type of biological material that may be necessary to treat specific patient need and can be configured for the many therapies that have been or will be developed.
Greg Bendis is Chief Executive Officer and leads the company, maintains its vision and values, directs its mission and oversees legal counsel. Greg has been in the field of Life Sciences and Medical Devices since 2007. Prior to that, he was a business consultant to some of the largest and most successful companies in the US; and, with the knowledge gained, founded and structured Reviticell based on principles that he discovered are common to all companies that succeed.
John Murray, MD is Chief Medical Officer. He develops and validates new medical technologies and directs Reviticell’s “Partner Physician” and Medical Services programs. Dr. Murray (who has been with Reviticell since its founding in 2011) is also head of Regenerative Medicine at University of Florida (a unique arrangement as a result of a written agreement with University of Florida). Dr. Murray recently relocated his lab from Gainesville to Jacksonville where the program will now be based (and the subject of a recent University of Florida Press Release).
Bob Cafferata, PhD is Science & Commercialization Advisor. He leverages scientific and industry insight to guide the commercialization of Reviticell products. Dr. Cafferata (who began working with Greg in 2008) is an industry veteran having worked at Medtronic where he was influential in technology acquisition and new business development. Also, among other industry roles, he was a part of the management team for Epic Therapeutics from inception to acquisition by Baxter International.
Arlene Bumb is Business Development Director and determines what new products should be developed and the nature/potential of applicable markets. Arlene (who began working with the Reviticell team in 2010) is also an industry veteran who worked at Medtronic, Thermo Fisher, Beckman Coulter, Pfizer, Boston Scientific, and St Jude Medical as well as start-up companies such as Pegasus Biologics, BioMedGPS, Halo Healthcare and PhageTech, Inc.
Leslie Frilling is Chief Logistics Officer and oversees Quality Assurance, Purchasing and strategic business partners who develop and produce company products. Leslie (who began working with Greg to develop the Reviticell business in 2009) has advised and worked with plastic surgeons and dermatologists throughout the US and for companies such as Johnson & Johnson where her insight was needed for the development of comprehensive skin-care centers in South America.
Gary Granfield is Chief Operations Officer and ensures proper promulgation of the Reviticell Way while also directing Physician Services and Site Services operations. Gary (who has been with Reviticell since 2011) previously founded a company which he led and grew to an enterprise that took him to more than 100 countries where he conducted business in many different cultural environments and where his fluency in seven languages served him well.
Mark Vickers is Chief Marketing Officer and directs Strategic Sales & Marketing, maintains company brand and oversees Sales & Distribution resources. Mark (who joined the Reviticell team in early 2016) previously founded a consulting practice which took him to assignments throughout the country where he shared his expertise in communication and sales strategies, process design and systems implementation.